Additional Effects of Box Breathing Technique With Short Term Pulmonary Rehabilitation on Dyspnea and Functional Capacity in Patients With Chronic Obstructive Pulmonary Disease

April 7, 2026 updated by: Foundation University Islamabad

Chronic Obstructive Pulmonary Disease is progressive and irreversible respiratory condition characterized by persistent airflow limitation leading to dyspnea and reduced functional capacity.

Pulmonary rehabilitation along with different technqiues of breathing exercises reduces dyspnea and enhance functional capacity by improving ventilatory efficiency, respiratory muscle control and overall exercise tolerance in patients with COPD.

Study Overview

Detailed Description

Chronic Obstructive pulmonary Disease is a progressive and irreversible respiratory condition characterized by persistent airflow limitation leading to dyspnea and reduced functional capacity.

Pulmonary Rehabilitation, a cornerstone in COPD management helps to reduce dyspnea and improve functional capacity. Although long-term PR programs yield sustained benefits, shorter-duration PR (e.g., 3-week interventions) may offer greater feasibility and higher patient adherence.

Total 40 participants will be allocated into two groups. Group A will be provided with short term Pulmonary rehabilitation along with pharmacological management and group B will be given additional Box breathing along with short term pulmonary rehabilitation The objective of this study is to determine the additional effects of Box breathing technique with short term pulmonary rehabilitation versus short term pulmonary rehabilitation alone on Dyspnea, Functional capacity and quality of life in patients with chronic obstructive pulmonary disease.

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Islamabad, Pakistan
        • Recruiting
        • Foundation University Islamabad
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age between 40-65 years
  • Both genders (male and female)
  • Grade 1-3 on mMRC scale of dyspnea
  • COPD mild stage according to global initiative for chronic obstructive lung -disease (GOLD) classification; Mild = FEV1 greater than or equal to 80% predicted

Exclusion Criteria:

  • Patients having acute exerbation of COPD
  • Patients diagnosed with acute infection (pmeumonia, T.B)
  • Any orthopedic or neuromuscular condition that hinders participation in exercise training program
  • Patients unable to follow command and instructions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Short term pulmonary rehabilitation

Patients in this group will receive Short term pulmonary rehabilitation along with pharmacological management.

Two sessions per week, supervised by physiotherapist will be conducted for a total of 3 weeks.

Patients in this group will receive short term pulmonary rehabilitation along with pharmacological management.

A total of 3 weeks protocol will be followed in which 2 seesions per week will be supervised by physiotherapist.

Short term pulmonary rehabilitation includes:

Warm-up(5-7min): light walking Aerobic training: mild-moderate intensity (40-60% of MHR) cycling or walk on treadmill/over ground Strength training: Exercises for major muscle groups (upper limb, lower limb and trunk) using body weight based on 1RM.

Upper limb: upright row, shoulder press, bicep curls Lower limb: sit-to-stand, mini knee lifts, 3 steps calf raises Core: Seated abdominal contraction, back extension Perform 1-2 sets of 5-10 repetitions for each exercise, resting 1-2 mins between sets.

Breathing exercise: pursed-lip breathing (1-3 sets of 5-10 reps) Cool down: (5-10min) Pharmacological management: Patient will receive medications as per prescribed by pulmonologist

Experimental: Box breathing with short term pulmonary rehabilitation

Patients in this group will receive Box breathing as well as short term pulmonary rehabilitation along with pharmacological management.

Two sessions per weeek, supervised by physiotherapist will be conducted for a total of 3 weeks. In Group B, box breathing will be performed daily.

A home diary will be provided in order to ensure and follow-up that the participants are performing breathing exercise at home.

Patients in this group will receive box breathing with short term pulmonary rehabilitation along with pharmacological management. A total 3 weeks protocol will be followed in which 2 sessions per week will be supervised by physiotherapist and box breathing will be performed daily.

Patient will receive short term pulmonary rehabilitation including:

Warm -up (5-7 min): light walking Aerobic training: mild-moderate intensity (40-60%of MHR) cycling or walk on treadmill/over ground.

Strength training: Exercises for major muscle groups (upper limb, lower limb and trunk) using body weight based on 1RM.

Upper limb: upright row, shoulder press, bicep curls Lower limb: sit-to-stand, mini knee lifts, 3 steps calf raises Core: seated abdominal contractions, back extensions Perform 1-2 sets of 5-10 repetitions for each exercise resting 1-2 min between sets.

Breathing exercise: pursed-lip breathing (1-3 sets of 5 -10 repetitions) Cool down: (5-10 min) Box breathing: The patient will be instructed

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Dyspnea
Time Frame: 03 weeks

Evaluation will be performed using the Modified Medical Research Council (mMRC) Dyspnea Scale, a clinician-administered scale ranging from 0 to 4, where:

0 indicates breathlessness only with strenuous exercise 4 indicates severe breathlessness (too breathless to leave the house or breathless while dressing) Higher scores represent worse dyspnea severity and poorer functional status.

03 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Functional Capacity
Time Frame: 03 weeks
Evaluation will be done by using 6 minute walk test
03 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 28, 2026

Primary Completion (Estimated)

May 15, 2026

Study Completion (Estimated)

May 15, 2026

Study Registration Dates

First Submitted

March 27, 2026

First Submitted That Met QC Criteria

April 7, 2026

First Posted (Actual)

April 8, 2026

Study Record Updates

Last Update Posted (Actual)

April 8, 2026

Last Update Submitted That Met QC Criteria

April 7, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Disease, Chronic Obstructive (COPD)

Clinical Trials on Short term Pulmonary Rehabilitation

Subscribe